Consolidative involved-node proton therapy for stage IA-IIIB mediastinal hodgkin lymphoma: Preliminary dosimetric outcomes from a phase II study

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 260-267

  Hoppe, Bradford S ^a   Flampouri, Stella ^a   Su, Zhong ^a   Morris, Christopher G ^a   Latif, Naeem ^a   Dang, Nam H ^a   Lynch, James ^a   Li, Zuofeng ^a   Mendenhall, Nancy P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dosimetry; Hodgkin lymphoma; Organs at risk; Proton therapy; Radiation therapy

Indexed keywords

DOSE REDUCTION; END POINTS; HODGKIN LYMPHOMA; INTENSITY-MODULATED RADIOTHERAPY; LONG-TERM FOLLOW-UP; MEAN DOSE; OPTIMIZED PLANS; ORGANS AT RISKS; PHASE II; PROTON THERAPY; RELATIVE REDUCTION; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT); UNIVERSITY OF FLORIDA;

BIOLOGICAL ORGANS; CARDIAC RESYNCHRONIZATION THERAPY; CHEMORADIOTHERAPY; CHEMOTHERAPY; DOSIMETRY; ONCOLOGY; PHYSICAL THERAPY; PROTON BEAMS; RADIOTHERAPY;

THREE DIMENSIONAL;

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADULT; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; DOSIMETRY; FEMALE; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; MEDIASTINUM CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BREAST; ESOPHAGUS; FEMALE; HEART; HODGKIN DISEASE; HUMANS; LUNG; MALE; MEDIASTINAL NEOPLASMS; ORGANS AT RISK; PROSPECTIVE STUDIES; PROTONS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; THYROID GLAND; TUMOR BURDEN; YOUNG ADULT;

EID: 84859828579     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1959     Document Type: Conference Paper

References (22)

1. K.C. Oeffinger, A.C. Mertens, and C.A. Sklar Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 2006 1572 1582
2. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
3. A. Engert, A. Plutschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
4. T. Girinsky, L. Specht, and M. Ghalibafian The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
5. T. Girinsky, M.R. van der, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
6. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
7. T. Girinsky, C. Pichenot, and A. Beaudre Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226
8. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
9. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
10. L.B. Travis, M. Gospodarowicz, and R.E. Curtis Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192
11. M. Tukenova, C. Guibout, and M. Hawkins Radiation Therapy and Late Mortality from Second Sarcoma, Carcinoma, and Hematological Malignancies after a Solid Cancer in Childhood Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print]
12. S.L. Wang, Z. Liao, and A.A. Vaporciyan Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699
13. L.S. Constine, N. Tarbell, and M.M. Hudson Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose Int J Radiat Oncol Biol Phys 72 2008 24 33
14. F.E. Van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J Natl Cancer Inst 95 2003 971 980
15. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors Blood 100 2002 1989 1996
16. K. Behringer, A. Josting, and P. Schiller Solid tumors in patients treated for Hodgkin's disease: A report from the German Hodgkin Lymphoma Study Group Ann Oncol 15 2004 1079 1085
17. M.L. De Bruin, J. Sparidans, and M.B. Van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
18. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955
19. B.A. Campbell, N. Voss, and T. Pickles Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size J Clin Oncol 26 2008 5170 5174
20. D.A. Mulrooney, M.W. Yeazel, and T. Kawashima Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort BMJ 339 2009 b4606
21. B.S. Hoppe, S. Flampouri, and Z. Li Reduction of cardiac, breast, lung, esophagus, and total body integral radiation dose with proton therapy in Hodgkin lymphoma (HL) patients with mediastinal involvement [Abstr.] Haematologica 95 2010 s44
22. S. Wang, Z. Liao, and X. Wei Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int J Radiat Oncol Biol Phys 66 2006 1399 1407